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A B S T R A C T   
Neuroglobin is the third member of the globin family to be identified in 2000 in neurons of both human and 
mouse nervous systems. Neuroglobin is an oxygen-binding globin found in neurons within the central nervous 
system as well as in peripheral neurons, that produces a protective effect against hypoxic/ischemic damage 
induced by promoting oxygen availability within the mitochondria. Numerous investigations have demonstrated 
that impaired neuroglobin functioning is implicated in the pathogenesis of multiple neurodegenerative disorders. 
Several in vitro and animal studies have reported the potential of neuroglobin upregulation in improving the 
neuroprotection through modulation of mitochondrial functions, such as ATP production, clearing reactive ox-
ygen species (ROS), promoting the dynamics of mitochondria, and controlling apoptosis. Neuroglobin acts as a 
stress-inducible globin, which has been associated hypoxic/ischemic insults where it acts to protect the heart and 
brain, providing a wide range of applicability in the treatment of human disorders. This review article discusses 
normal physiological functions of neuroglobin in mitochondria-associated pathways, as well as outlining how 
dysregulation of neuroglobin is associated with the pathogenesis of neurodegenerative disorders.   
1. Introduction 
Neurological damage, such as brain trauma or cerebral stroke, is 
associated with high mortality and intense chronic disability throughout 
worldwide population [1,2]; such disorders significantly reduce a pa-
tient’s quality of life and life expectancy. Nonetheless, there has been 
little success in developing effective treatments to improve post-trauma 
recovery. Current treatments for neurodegenerative disorders aim to 
reduce the severity of the symptoms with little effect on halting disease 
progression [3]. 
Stimulation of endogenous neuroprotective mechanisms has been 
investigated as a possible approach for devising therapies to treat 
neurological complications. In addition, administration of these neuro-
protective compounds may also confer beneficial effects. One possible 
key target is neuroglobin, a vertebrate globin family involved in cellular 
oxygen homeostasis [4]. Neuroglobin is primarily expressed in the 
central nervous system (CNS), and is located in the cytoplasm, inside 
mitochondria, nucleus and subcellular cell cytoplasm. Among the 
different brain areas, the hypothalamus has been attributed with the 
highest expression of neuroglobin [5]. The function of neuroglobin is to 
promote the cell viability during hypoxia as well as oxidative stress. 
Therefore, Studies have reported a neuroprotective function for 
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neuroglobin, as its expression is negatively associated with the intensity 
of histological complications and functional impairments in patients 
with stroke and neurodegenerative disorders in in vitro studies and an-
imal experiments [6,7]. Nevertheless, there is little data with respect to 
the mechanisms underlying the neuroprotective role of neuroglobin [8]. 
A number of hormones like vessel endothelial growth factor (VEGF) can 
induce the production of neuroglobin, suggesting another approach to 
increase the production of neuroglobin for the therapeutic purposes [9]. 
The mitochondria are involved in several vital cellular process, 
including homeostasis of calcium, energy supplication, redox signaling, 
production of ROS and programmed cell death [10,11]. Neuronal cells, 
especially, rely on effectively functioning mitochondria to maintain the 
high energy demand of the brain [12]. Impaired mitochondrial func-
tioning has been associated with numerous diseases of CNS, including 
Alzheimer’s disease, Huntington disease, and Parkinson’s disease [13, 
14]. Previous studies have demonstrated that neuroglobin is expressed 
in cells that have active metabolism and depend on oxygen consumption 
[15]. As a consequence, there might be a functional association between 
mitochondrial function and neuroglobin level in cells. This review will 
discuss the neuroprotective actions of neuroglobin in mitochondrial 
regulation, as well as outline how neuroglobin could be used to improve 
our understanding of the pathogenesis of neurological disorders, stroke, 
and hypoxia and contribute to designing novel therapeutics for such 
disorders. 
1.1. Evidence of neuroglobin-mediated neuroprotection 
Numerous investigations have indicated that neuroglobin plays a 
neuroprotective role in multiple neurological diseases (Fig. 1). In vitro 
experiments have demonstrated that knockdown of neuroglobin results 
in increased vulnerability of cortical neurons to hypoxia [16]. 
Conversely, overexpression of neuroglobin produces significant protec-
tion against hypoxia in the neurons in vitro [16]. Similarly, enhanced 
overexpression of neuroglobin (approximately 100-fold increase) in a 
neuroblastoma cell line protected the neurons against oxygen/glucose 
deprivation (OGD) conditions [17,18]. Overexpression of neuroglobin 
in a neuroglobin-transgenic mouse stroke model ameliorated the in-
tensity of clinical disease course, and improved histological, as well as 
functional impairments [19]. Additionally, neuroglobin knockdown in 
rats exacerbated the manifestations of focal cerebral ischemia in the 
animals [7]. In vivo experiments using double transgenic mice for neu-
roglobin and amyloid precursor protein (APP) suggested that neuro-
globin overexpression plays a protective role against β-amyloid-induced 
neurotoxicity, as well as Alzheimer’s disease pathogenesis [20]. In this 
regard, overexpression of neuroglobin in transgenic mice resulted in 
protection of retinal ganglion cells against glaucomatous damage and 
ocular hypertension [21]. With respect to several protective mecha-
nisms by neuroglobin, such as ROS scavenging and ATP conservation, 
strategies aiming to upregulate of neuroglobin expression may offer a 
potentially effective therapeutic approach for the treatment of neuro-
degenerative diseases [22]. 
According to the available evidence, the neuroprotective mechanism 
of neuroglobin is a consequence of modified mitochondrial functioning, 
such as reduced ROS production, improved ATP generation and altered 
cell death signaling, which will be discussed in the following sections. 
1.2. ROS production in mitochondria and neuroglobin 
Evidence show the involvement of neuroglobin in the production of 
reactive nitrogen species (RNS) and ROS [23]. Production of ROS occur 
at the termination of mitochondrial respiration, in which complex I and 
III transfer electrons to oxygen resulting in the production of superoxide 
anions [24]. Higher amounts of superoxide anions are generated when 
the electron carriers bear extra electrons, including disorders in which 
oxidative phosphorylation is prevented. 
It has been reported that neuroglobin is involved in scavenging the 
NO species, as well as ROS. Overexpression of neuroglobin in the neu-
roglobin transgenic mouse significantly decreased the production of 
superoxide anion upon hypoxia/reoxygenation in the cortical neurons 
compared to wild-type mice [25]. Neuroglobin has the ability to bind to 
NO [26] which helps to protect against NO-induced neurotoxicity [27], 
demonstrating that neuroglobin plays a critical role in neutralizing the 
Fig. 1. Effects of neuroglobin (Ngb) in neuronal cells. The beneficial effects of Ngb has been reported not only at the structural level but also on cell organelles. 
(A) Cellular alterations have been found in different brain pathologies, these include condensation of actin filaments and microtubules, mitochondrial aggregation 
and increased release of calcium (Ca2+) from the reservoir of the endoplasmic reticulum (ER), leading to the uptake of this ion by the mitochondria to cause 
mitochondrial dysfunction. Mitochondrial dysfunction involves damage to mitochondrial membranes, degradation and release of Cytochrome c (Cyt c), thus pro-
ducing more calcium (B) Beneficial effects of Ngb favoring transitory mitochondrial movement and enhanced ATP production. Ngb has been found to be associated 
with the regulation of calcium channels at the cellular level, especially on the ER, with a positive impact on reducing calcium release, which favors the maintenance 
of Cyt c within the mitochondrial intermembrane space and prevents the release of apoptosis inducing factor (AIF) while maintaining cell survival. Another effect that 
has been reported is the effect of Ngb on cell signaling pathways, such as that of Akt, a protein that can be phosphorylated by Ngb, favoring reduced apoptosis. Ngb 
also has the ability to trigger mitokATP receptor activity, which stimulates the reduction of reactive species such as H2O2 with a consequent decrease in oxidative 
cell damage. 
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neurotoxic effects of RNS. This observation further supports the neuro-
protective effects of neuroglobin. Additionally, overexpression of neu-
roglobin in the neuroglobin transgenic mouse with ischemia-reperfusion 
injury was shown to be correlated with decreased ROS/RNS generation, 
as well as reduced lipid peroxidation and injury rate in the CA1 region of 
the hippocampus [28]. Nonetheless, the exact mechanisms underlying 
this effect has not been found. It may be attributed to the direct binding 
of neuroglobin to ROS/RNS or the interaction of neuroglobin with the 
components of the mitochondrial respiration chain, such as mitochon-
drial complex III [22,29], as well as indirectly improving mitochondrial 
functioning. Using recombinant humanized neuroglobin, Li et al. (2011) 
reported that neuroglobin possesses a direct antioxidant effect by 
scavenging multiple free radicals, such as hydrogen peroxide, superox-
ide anion, hydroxyl radical and 2,2′-azino-bis(3-ethyl-
benzothiazoline-6-sulfonic acid) diammonium salt radical cation [30]. 
Additionally, this study demonstrated that recombinant humanized 
neuroglobin had a limited ability to scavenge the superoxide anion, but 
this effect was better than GSH and comparable with vitamin C [30]. 
Further in vivo and clinical studies are required to determine whether 
neuroglobin could improve recovery post-stroke by enhancing the 
scavenging of free radicals and preserving neurological functioning. 
1.3. Neuroglobin is involved in ATP generation within mitochondria 
Studies have also demonstrated that neuroglobin closely interacts 
with mitochondria in addition to its cytoplasmic effects. Electron mi-
croscopy and immunocytochemistry studies have demonstrated that 
neuroglobin in neurons is located within the mitochondria, nucleus and 
subcellular cell cytoplasm [31]. Kanai et al. (2001) also revealed that 
neuroglobin in neurons is colocalized with nitric oxide synthase (NOS) 
enzyme, suggesting that neuroglobin directly interacts with the mito-
chondria [32]. Similar results were reported by Lechauve et al. (2012), 
where neuroglobin was localized inside the mitochondria of retinal 
neurons [33]. Moreover, in vitro experiments of cortical neurons indi-
cated that only 10% of the total neuroglobin was localized in mito-
chondria [29]. 
In spite of neuroglobins ability to bind O2, the major function of 
neuroglobin might not be the transportation of O2 and delivering it to 
neurons. Neuroglobin has a high affinity for O2 but a low detachment 
rate, therefore, it is more likely that neuroglobin plays an important role 
in sensing O2 and maintaining energy metabolism of cells by conserving 
ATP levels [34,35]. Research has demonstrated that there is an associ-
ation between stroke onset and ATP disturbances. Within the ischemic 
core area, the remarkable decrease in blood supply culminates in 
reduced glucose and O2 supply, hence, very little ATP is generated [36, 
37]. Dysregulation of ATP levels indicates disrupted oxidative meta-
bolism in the mitochondria, resulting in lactate production [36]. Along 
with decreased ATP levels during ischemia, the respiratory capacity of 
mitochondria is significantly reduced in the penumbra area of brain, as 
well as within the core [38,39]. The respiratory capacity of mitochon-
dria can be returned temporarily after reperfusion, but decreased 
gradually over time [40]. The release of cytochrome c (Cyt c) from the 
mitochondria, as well as oxidative stress are plausible mechanisms for 
impaired respiratory function in mitochondrial [41,42]. 
Overexpression of neuroglobin has been observed in the retina, 
specifically neuroglobin within photoreceptors is localized to the mito-
chondria where higher levels of oxygen in the retina are consumed [43]. 
In addition, research has indicated the involvement of neuroglobin in 
preserving the function of the mitochondria towards triggers such as 
DNA damage, increased calcium levels, low nutrient levels, receptor 
signaling, oxidative stress, and aggregation of misfolded proteins [44]. 
Transfection of PC-12 cells with pcDNA3-neuroglobin enhanced cell 
survival and improved mitochondrial dysfunction following amyloid β 
administration [45]. Furthermore, chicken β − action promoter was used 
to increase the expression of neuroglobin in neuroglobin transgenic 
mice, resolving the aggregation of mitochondria induced by hypoxia and 
protected the neurons from apoptosis [46]. In vitro overexpression of 
neuroglobin in cortical neurons obtained from neuroglobin transgenic 
mouse resulted in amelioration of mitochondrial function. In addition, 
during the first stages of hypoxia/reoxygenation, neuroglobin over-
expression resulted in attenuation of ATP levels [25]. In a similar way, 
transfection of SH-SY5Y cells with pDEST40-neuroglobin plasmid led to 
upregulation of neuroglobin expression which produced a remarkable 
attenuation of H2O2-induced oxidative stress and a promoted levels of 
intracellular ATP [47]. Additionally, increasing the expression of neu-
roglobin through transfection of human neuronal cells by 
pDEST40-neuroglobin plasmid promoted cell survival and prevented the 
reduction in ATP following hypoxia/reoxygenation [48]. On the con-
trary, knocking down neuroglobin appears to dampen mitochondrial 
function, leading to increased ROS and poorer cell survival rate when 
astrocytes and microglia are subject to metabolic dysfunction [9,49]. 
Most neuroprotective actions of neuroglobin on mitochondria are 
sought to happen through activation of estrogen receptors, as neuro-
globin expression is upregulated when estradiol signaling is triggered 
[50,51]. Taken together these results demonstrate that neuroglobin 
plays an important role in conserving ATP generation in mitochondria. 
This can be implemented by either maintaining the general function of 
mitochondria or particular effect on mitochondrial respiration, 
requiring further studies for detailed clarification of the mechanism. 
Neuroglobin is primarily found in the cell cytoplasm [52], where it 
plays a function as guanine-nucleotide-dissociation inhibitor (GDI) and 
modulate the cell signaling [53]. Research has identified that 
neuroglobin-binding proteins by yeast two hybrid assay indicated that 
neuroglobin binds to mitochondrial complex III subunit, namely cyto-
chrome c1 [54]. Recently, it was disclosed that the negative charges on 
the neuroglobin’s surface play a role in its interaction with cytochrome c 
[55]. Functional evaluations indicated reduced activity of mitochondrial 
complexes I and III after neuroglobin knockdown [33]. Hence, it seems 
that by binding to mitochondrial respiratory complexes and influencing 
their functions, neuroglobin plays a key role in ATP generation. Several 
studies have confirmed the subcellular localization of neuroglobin and 
its interaction with mitochondria. Hundahl et al. (2012) suggested that 
utilizing an anti-neuroglobin antibody is the most reliable approach to 
detect the subcellular localization and function of neuroglobin [56]. 
Conversely, neuroglobin-null mice model have now been introduced as 
the most reliable validating technique for future studies [57]. As a 
consequence, the previous results about the subcellular localization of 
neuroglobin through immunostaining need to be interpreted with 
caution. 
1.4. Neuroglobin and apoptosis signaling in mitochondria 
In addition to ROS scavenging and ATP generation, neuroglobin is 
involved in signaling mechanisms (Fig. 2). Ferric neuroglobin has the 
potential to bind to the guanosine diphosphate (GDP)-bound state of the 
G protein α⋅(Gα) subunit, where it acts as a guanine-nucleotide disso-
ciation inhibitor (GDI) [53]. The conversion of GDP for GTP is inhibited 
by ferric neuroglobin, preventing the Gα subunit from binding to the Gβγ 
complex. This in turn triggers downstream signaling transduction, 
resulting in oxidative stress protection [58]. 
The intrinsic pathway of apoptosis is mediated by the mitochondria, 
where several pro-apoptotic and anti-apoptotic proteins are involved, 
including Bcl-2 and Bcl-xL, Bax, Bak, Bid, Bim, Bad and PUMA [59]. 
Upon disruption of the mitochondrial membrane, caspase-dependent 
and caspase-independent apoptotic pathways are activated due to the 
release of Cyt c and apoptosis-inducing factor (AIF) into the cytoplasm, 
respectively. From here, Cyt c binds to Apaf 1 in cytoplasm, initiating the 
assembly of apoptosomes, leading to caspase 9 activation which stim-
ulates caspase 3 and caspase 7 [60]. Secondly, in the 
caspase-independent apoptosis pathway AIF is transferred into the nu-
cleus and modulates important steps of apoptosis, such as comprising of 
chromosome and fragmentation of DNA strands [61]. 
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ROS produced in the mitochondria plays a role in signaling 
apoptosis. The primary data concerning the implications of mitochon-
drial ROS in apoptosis originated from studies about cell cytotoxicity 
induced by tumor necrosis factor (TNF) − α [62]. Research utilizing 
antioxidants or techniques for overproduction of ROS have established a 
vital role of ROS in apoptosis signaling [63]. As neuroglobin is involved 
in scavenging ROS, it is probable its involvement in controlling 
apoptosis signaling in neurons. In vitro neurons isolated from 
neuroglobin-transgenic mice resulted in downregulation of cell death 
triggers within the neurons, such as reduced aggregation of mitochon-
dria and hypoxia-induced microdomain polarization [46]. Moreover, in 
vitro studies have also indicated that neuroglobin inhibits the intrinsic 
apoptosis pathway in human neuroblastoma SH-SY5Y cells by inter-
rupting the activation of pro-caspase 9 by interacting with Cyt c [64]. 
Dai et al. (2019) demonstrated that increased neuroglobin expression in 
rats led to improved recovery following spinal cord injury. This was 
attributed to reduced apoptosis and lesions in the spinal cord tissues. 
Additionally, this study reported upregulation of caspase 3, Cyt c and 
bax levels, while reducing bcl-2 expression, within the spinal cord tis-
sues [65]. Conversely, Chen et al. (2018) reported upregulation of bcl-2 
and downregulation of caspase 3, caspase 9 and Bax when recombinant 
neuroglobin was administered in rabbits suffering from subarachnoid 
hemorrhage. This study also observed that TAT protein transduction 
domain facilitated the delivery of neuroglobin into brain neurons, 
leading to inactivation of the mitochondrial apoptotic pathway [66]. In 
addition, TAT-neuroglobin was indicated to protect the neuron-like cells 
from OGD-induced apoptosis by activating the Jak2/Stat3 pathway 
[67]. 
Opening of the permeability transition pore (PTP) on the mito-
chondrial membrane leads to the release of Cyt c into the cytoplasm 
[68], where caspase-dependent or caspase-independent apoptosis 
pathways are initiated. Upregulation of neuroglobin expression by 
transduction of mouse cortical neurons with AAV-neuroglobin was 
found to reduce the opening of mitochondrial PTP, leading to a decline 
in the release of Cyt c after OGD and reoxygenation [69]. Hence, it seems 
that neuroglobin plays a neuroprotective role against apoptosis by 
repressing the OGD-induced mitochondrial PTP opening. In addition to 
decreasing the release of Cyt c through inhibition of mitochondrial PTP 
opening, neuroglobin has been shown to improve cell survival through a 
variety of anti-apoptotic mechanism. Fago and colleagues (2006) 
demonstrated that neuroglobin plays a role in the redox reaction of 
ferric Cyt c to ferrous Cyt c [70], leading to apoptosis inhibition. This is 
because Cyt c is released from the mitochondria in the form of ferric Cyt 
c [71], and this form, but not ferrous Cyt c, is functional in stimulating 
apoptosis [72]. As a consequence, ferrous Cyt c produced by neuroglobin 
becomes non-functional and does not stimulate apoptosis. Bioinformatic 
evaluations have demonstrated that when neuroglobin binds to Cyt c the 
redox reaction aftermath inhibits the activation of caspase 9 [73]. 
Neuroglobin binding to Cyt can also directly reduce the level of released 
Cyt c from mitochondria. 
Calcium plays a central role in a variety of key cell signaling path-
ways, including apoptosis [74]. The endoplasmic reticulum (ER) is the 
main storage of calcium in cellular cytoplasm [75]. Calcium is involved 
in regulating mitochondrial morphology, as well as controlling mole-
cules involved in apoptosis. Upon apoptotic signaling, ER releases cal-
cium which is then absorbed by the mitochondria, leading to enhanced 
Cyt c leakage from the mitochondria [76]. Released Cyt c binds to the 
inositol trisphosphate receptor (IP3R) on the ER, resulting in further 
calcium release, further enhancing the release of Cyt c from more 
mitochondria and stronger signaling of apoptosis [77]. By controlling 
cytoplasmic calcium concentrations, neuroglobin has been shown to 
regulate apoptosis in response to cell death triggers. Upregulation of 
neuroglobin expression using pDEST40-neuroglobin plasmid trans-
fection of neurons was shown to inhibit the increment of cytoplasmic 
calcium level after hypoxia/reoxygenation [48]. Neuroglobin may 
control calcium levels by modulating transporters on the cell membrane 
or calcium channel on the ER membrane. In addition to regulating cal-
cium levels, neuroglobin interrupts apoptosis by indirectly controlling 
the quality and quantity of apoptosis-related molecules. Research has 
shown that overexpression of neuroglobin following transfection of 
Fig. 2. Neuroglobin (Ngb) reduces oxidative damage and maintains optimal ATP levels in the brain. Ngb has an affinity for oxygen and acts as a sensor that 
enables the reduction of reactive oxygen species, such as hydroxyl ion (OH− ), superoxide (O2− ) and hydrogen peroxide (H2O2), as well as an affinity for reactive 
nitrogen species, such as nitric oxide (NO), and favors the elimination of other free radicals such as 2,2′-azino-bis (3-ethylbenzothiazoline-cation radical of dia-
monium salt (6-sulfonic acid). Together these findings confirm that Ngb has a direct antioxidant potential that promotes cell survival and reduces lipid peroxidation 
in the brain. It is also evident that Ngb is related to the preservation of mitochondria function and the maintenance respiratory complexes I and III, which in turn, 
favor the production of ATP. 
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SH-SY5Y cells with pDEST40-neuroglobin plasmid led to Akt phos-
phorylation and activation of mitochondrial ATP-sensitive potassium 
(KATP) channel, shielding the cell against H2O2-induced injury [47]. 
Neuroglobin-induced phosphorylation of Akt prevents Cyt c and AIF 
release, resulting in apoptosis suppression [78]. Cell culture studies 
indicated that neuroglobin promotes Akt phosphorylation and plays a 
protective role in astroglial, due to inhibition of H2O2-induced oxidative 
stress and apoptosis [79]. 
Research has demonstrated that modulating apoptosis can produce 
neuroprotective effects in animal models [80]. Inhibition of caspase-3 
and caspase-9 in rat/mice model of stroke improved brain tissue loss 
and ameliorated neurological outcomes [81–83]. With respect to neu-
roglobin’s potential to interrupt apoptosis in neurons, enhancing the 
expression of neuroglobin might provide a promising approach in the 
regulation of apoptosis in neurodegenerative diseases. Assessing the 
endogenous factors involved in the regulation of neuroglobin expression 
may lead to devising a therapeutic tool for treatment of brain diseases 
[22]. 
1.5. Neuroglobin and the mitochondrial dynamics 
Mitochondrial dynamics involves continuous fusion and fission 
procedures which is critical for supplying the energy required for 
transportation and channel functioning. In addition, mitochondria un-
dergo mitophagy, through which impaired and non-functional mito-
chondria are degraded in order to ensure continued functioning of 
quality mitochondrial systems. Neurodegenerative disorders have been 
characterized by impaired mitochondrial dynamics [84,85]. Consid-
ering the role of neuroglobin in the generation of ATP and mitochondrial 
energy production, as well as in mitochondrial aggregation upon hyp-
oxia, neuroglobin may preserve mitochondrial dynamics [46]. 
In the fusion process of mitochondria the two dynamin-like proteins, 
Mfn1/Mfn2 and OPA1, are required [86], whereas Fis1 and 
dynamin-related protein 1 (Drp1) are involved in fission of mitochon-
dria [87]. Research has suggested that there is a correlation between 
impaired mitochondrial fission/fusion processes in neurodegenerative 
disorders because mitochondrial fission was seen to be an early event in 
diabetic neuropathy and ischemic stroke [88,89]. To apply this mech-
anism in therapeutics, Barsoum et al. (2006) demonstrated that over-
expression of Mfn1 or knockdown of Drp1 gene led to suppressed 
mitochondrial fission, which in turn culminated in protection against 
NO-induced neuronal cell death [89]. Similarly, Liu and colleagues 
revealed that upon transient middle cerebral artery occlusion in mice 
there were downregulation of Drp1 and Opa1 in the ischemic core area, 
while both were upregulated in in the ischemic penumbra [90]. These 
results imply fusion and fission of mitochondria was conserved in sur-
viving ischemic penumbra. 
Mobilization of mitochondria toward the subcellular locations like 
presynaptic terminals are required to supply energy to high demand 
regions [91]. Actin microtubules are involved in the transportation of 
mitochondria that are composed of dynein and kinesin, the 
ATP-dependent molecules involved in cellular movements [92,93]. 
Adaptor proteins, such as MIRO1, MIRO2, TRAK1 and TRAK2, are 
involved in modulating the indirect binding of kinesin to the mito-
chondria [94,95]. Synaptic activity and, hence, neuron viability depend 
on the movements and distribution of mitochondria in neuronal cells 
[96]. Cortical neurons in vitro have been shown to present with impaired 
transport and cell morphology following hypoxia/reoxygenation [97]. 
Proper and timely degradation of damaged or aged mitochondria is 
crucial for maintaining mitochondrial quality control. Mitophagy plays 
a key role in clearing the impaired and aged mitochondria to be replaced 
by newly developed organelles [98]. PTEN-induced putative kinase 1 
(PINK1) and Parkin play vital roles in this mitophagy process [99–101]. 
Interestingly, ischemic preconditioning has been shown to trigger 
mitophagy by enhancing the transfer of Parkin into the mitochondria. 
This protective preconditioning effect was attenuated following 
knocking out of the Parkin gene [102]. Mitophagy has also been shown 
to be involved in the pathophysiology of neurodegeneration. In inheri-
ted ataxias, upregulation of mitophagy resulted in degenerating of 
Purkinje neurons, implying that appropriate control of mitophagy is 
required to allow for proper functioning of neurons [103]. Taken 
together, neuroglobin by affecting on the generation of ATP and mito-
chondrial energy supply, and mitochondrial aggregation after hypoxia, 
it appears to play a role in the mitochondrial dynamics, suggesting its 
involvement in the neurological disorders. 
Upregulation of neuroglobin prevents the aggregation of neurons 
following hypoxia [46]. Following Cyt c release from the mitochondria 
in presence of apoptosis-inducing signals, mitochondrial aggregation 
occurs due to abnormal transport of mitochondria [46,104]. Further-
more, previous studies indicate that upregulation of neuroglobin is able 
to resolve the condensation of actin microtubules following induction by 
H2O2, suggesting neuroglobin has a key role in maintaining the integrity 
of the cell membrane [47]. Since the transient migration of mitochon-
dria throughout the cytosol in neurons rely on actin microtubules, 
neuroglobin might play an indirect function in promoting this process 
[105]. Despite the literature on the role of neuroglobin in mitochondria 
migration, more studies should be carried out to assess the mechanisms 
underlying neuroglobin function in modulating the mitochondrial dy-
namics and its involvement in the etiopathogenesis of neurodegenera-
tive disorders. 
1.6. Neuroglobin-mitochondria crosstalk at molecular level 
There are numerous proteins and molecules inside mitochondria that 
originate from cytosol and are transported into mitochondria when a 
neuroinflammatory stimulation occurs. Amongst these proteins, bcl-2 
family members are the most important apoptosis-related molecules 
that respond to cell death signals [59]. Other than exogenous 
apoptosis-related molecules, mitochondria also harbor an number of 
endogenous molecules related to apoptosis, such as neuroglobin, that 
play a role in supporting and protecting neuronal cells [29]. Other than 
mediating apoptosis signaling, ROS production and ATP production, 
neuroglobin has been indicated to interact with other molecules, such as 
ubiquitin C, Na/K ATPase beta 1, voltage dependent anion channel 
(VDAC), and Cyc 1 [54]. Among the neuroglobin-binding molecules, Cyc 
1 and VDAC have been shown to play an important role in maintaining 
the survival and protection of neurons. Cyc 1 is associated with patho-
logical conditions and has been implicated in oxidative stress and 
modulation of hypoxia inducible factor-1 alpha (HIF-1α) when hypoxic 
conditions occur [106]. Additionally, VDAC has a key role in mediating 
the opening of mitochondrial PTP [107], leading to the release of Cyt c 
into the cytoplasm [68] and initiation of apoptosis pathways. On the 
other side, neuroglobin reduces the release of Cyt c by preventing the 
opening of mitochondrial PTP opening [70]. OGD/reoxygenation was 
indicated to mediate the localization of neuroglobin in mitochondria 
[29]. However, the detailed function of neuroglobin in mitochondria 
and its binding with mitochondrial proteins requires further 
investigation. 
2. Conclusions 
Neuroglobin is an endogenous neuroprotective protein that plays a 
role in several neurodegenerative conditions (Fig. 2). Mitochondria play 
a vital role in mediating apoptosis or neuronal survival in multiple 
neurodegenerative disorders. They do this by modulating several 
physiological cellular processes, including oxidative stress, energy 
metabolism and apoptosis signaling. Neuroglobin has an active role in 
protecting the cell against oxidative stress by degrading ROS, main-
taining ATP sources and modulating apoptosis. Moreover, neuroglobin 
organizes the movement of mitochondria inside cell for important 
physiological requirements. The modulation of the mitochondrial dy-
namics by neuroglobin might opens up novel avenues in the field of 
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neuroglobin and neurodegenerative diseases. Recent approaches, like 
nanoparticles, to deliver neuroglobin to the brain might be promising in 
the treatment of neurological diseases [108,109]. Nonetheless, the 
precise interactions among neuroglobin and proteins with biological 
function in mitochondria have not been fully explored. Experimental 
models using neuroglobin suggest that neuroglobin is a valuable tool in 
the treatment of neurodegenerative diseases; however, further in-
vestigations are required to confirm the exact mechanisms of action of 
this globin [110]. When a complete picture of how neuroglobin func-
tions is available, one can target this signaling pathway to design ther-
apeutics which enhance the beneficial effects of neuroglobin in 
neurodegenerative disorders. 
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